Welcome to our dedicated page for Wearable Devices Ltd. news (Ticker: WLDS), a resource for investors and traders seeking the latest updates and insights on Wearable Devices Ltd. stock.
Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) appears frequently in technology and capital-markets news due to its focus on AI-powered neural input touchless wearables. Company press releases highlight developments around its Mudra Band and Mudra Link neural wristbands, which are described as defining a neural input category for wrist-worn devices and brain-computer interfaces. News coverage often centers on how these products enable gesture-based control of smart-glasses, screens and other digital devices.
Investors and technology followers tracking WLDS news will see updates on product features, platform support and ecosystem integrations. Recent announcements describe Mudra Link applications designed for multiple operating systems, compatibility with select smart-glasses models, customized presets for common functions, and demonstrations where Mudra Link acts as an alternative to traditional input devices. The company also reports collaborations with smart-glasses manufacturers and participation in events such as CES, where it showcases neural-click timing, gesture creation and live neural intent visualization.
WLDS news items additionally cover research, clinical pilots and financing activities. Examples include an EMG-based weight-estimation capability built on a U.S. patent, a neurorehabilitation pilot with Soroka University Medical Center focused on grip-force control, and grant support from the Israel Innovation Authority. On the corporate side, press releases and accompanying Form 6-K filings discuss registered direct offerings, warrant transactions, and distribution agreements in regions such as South Korea and other Asian markets.
For readers interested in the intersection of neural interfaces, XR and public markets, the WLDS news feed provides an ongoing record of how Wearable Devices communicates its product roadmap, partnerships and capital-raising steps. Returning to this page allows users to follow new announcements as the company furnishes additional press releases and regulatory disclosures.
Wearable Devices (Nasdaq: WLDS) will demonstrate neural-input control for smart-glasses and large screens at CES 2026 in Las Vegas, showcasing hands-on demos of the Mudra Link neural band at booth 15650. The exhibit includes a Neural-Click latency comparison, a Neural Gesture Lab for on-device gesture creation and training, a Live Neural Intent Visualizer, and smart-screen and smart-glasses control demos including Google Android XR and Galaxy XR compatibility.
The company will host private partner demonstrations and strategic discussions in a meeting room to explore advanced neural-input features for smart-glasses platforms in development.
Wearable Devices (Nasdaq: WLDS) announced a collaboration with Rokid to integrate Mudra Link wrist-based neural gesture control with Rokid Glasses, targeting a consumer bundle rollout in Q2 2026. The partnership covers out-of-the-box pairing, pre-mapped gestures, a shared setup flow, joint marketing and CES demonstrations on Jan 6–9, 2026. Rokid Glasses weigh 49 grams and include a 12MP first-person camera, Micro LED waveguide displays and integrated audio. Wearable Devices says the duo aims to simplify hands-free control for everyday AI tasks like translation, navigation and transcription.
Wearable Devices (Nasdaq: WLDS) announced two Mudra Link updates on December 22, 2025: customized presets and on‑device Mudra Link compatibility for select smart‑glasses models. The presets map common functions (back, home, play/pause, volume) to wrist gestures and can be applied or edited by users. Running Mudra Link directly on supported glasses lets users pair devices, complete onboarding, adjust the gesture mapper and apply customized settings without a PC or phone.
Wearable Devices says the changes aim to reduce onboarding friction, shorten setup time and deliver cross‑brand gesture consistency; rollout begins Q1 2026 with more models added through the year.
Wearable Devices (Nasdaq: WLDS) received Israel Innovation Authority approval for a $750,000 non-dilutive grant to fund a clinical pilot with Soroka University Medical Center announced on December 11, 2025.
The pilot will test the company’s Mudra Link neural wristband using surface neural EMG to provide real-time objective biofeedback for patients with impaired grip-force control after motor-cortex brain injuries. The program aims to validate Mudra Link as a home-capable, cost-effective rehabilitation tool that delivers quantitative performance metrics and may complement the company’s neural interaction portfolio.
Wearable Devices (Nasdaq: WLDS, WLDSW) entered a warrant inducement agreement announced Nov 28, 2025, to raise approximate gross proceeds of $5.68 million.
The Investor will immediately exercise Existing Warrants to buy up to 3,322,000 ordinary shares at $1.71 per share. In a private placement, the company will issue new unregistered warrants to purchase up to 5,813,500 ordinary shares at an exercise price of $1.86, exercisable after shareholder approval and expiring five years after the Approval Date. The closing is expected on or about Dec 1, 2025, subject to customary conditions. Net proceeds will fund working capital and general corporate purposes.
Wearable Devices (Nasdaq: WLDS) announced a technical roadshow in China on Nov. 24, 2025, with senior management conducting deep technical sessions in Shenzhen, Shanghai, and Beijing.
Top-tier consumer‑electronics manufacturers in China have requested closed‑door evaluations to test the company’s Mudra neural band as a hands‑free intent‑to‑action input layer for next‑generation AI smart glasses slated in many companies’ 2026–2027 roadmaps. The company said industry interest is accelerating development timelines in the Asian hardware ecosystem and reinforces Asia as a central pillar of its growth strategy.
Wearable Devices (Nasdaq: WLDS) announced on November 18, 2025 a pre-commercial EMG-driven weight-estimation capability running on its Mudra Link neural wristband, implemented under a recently granted U.S. patent covering measurement of weight, torque, and applied force from the wrist.
The model analyzes surface EMG during lifting actions and is being used for internal testing, benchmarking, and proofs of concept. Potential applications cited include robotics, industrial automation, sports technology, healthcare, and extended reality (XR).
Wearable Devices (Nasdaq: WLDS) announced an exclusive distribution agreement with Sky Commerce to sell the Mudra Band and Mudra Link neural wristbands in South Korea, effective November 7, 2025.
Sky Commerce will promote, market, and sell the products in Korea subject to annual minimum purchase targets, and both companies are completing required KC certification before sales begin. The deal follows a recent distribution agreement in Japan and aims to scale the company’s AI-powered touchless sensing wearables across Asia.
Wearable Devices (Nasdaq: WLDS) announced on November 5, 2025 the successful completion and delivery of a jointly developed neural interface system with X-trodes for advanced tactical systems. The touchless human–machine interface uses X-trodes SmartSkin EMG patches, artifact immunity mechanisms, and Wearable Devices’ classification algorithms to enable control of communication, navigation, and command systems via subtle neuromuscular activity and gestures without manual input.
The system has been delivered to customers for evaluation and use in extreme environments, meeting operational and performance milestones, and is presented as a foundation for potential future development phases to transform interfaces in extreme environments.
Wearable Devices (Nasdaq: WLDS, WLDSW) announced a registered direct offering and concurrent private placement to an existing institutional investor.
The company agreed to sell 1,230,000 ordinary shares at $2.67 per share for gross proceeds of approximately $3.3 million (before fees). In a concurrent private placement, the company will issue unregistered warrants to purchase up to 1,230,000 ordinary shares at an exercise price of $2.67, exercisable upon shareholder approval and expiring five years after such approval. The closing is expected on or about October 31, 2025, subject to customary conditions. The company also agreed to amend existing warrants issued in September 2025 to reduce their exercise prices to $2.67 (affecting up to 1,670,000 shares), subject to shareholder approval. Net proceeds will be used for working capital and general corporate purposes.